Feed 6160.HK
61
BeOne Medicines AG
6160.HK · HKSE
$211.20 -3.74% (-$8.20)
1M +10.29%
Market Cap $35.8B
P/E Ratio 124.69x
Div. Yield -
ROE 7.11%
Bulios Fair Price
$242.65
14.9% upside
Current Price
$211.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6160.HK is currently undervalued relative to its market price. How does it work?
Piotroski F-Score Moderate
6/9Valuation
10 /100
Expensive P/E 124.69x
EV/EBITDA 54.84x
P/S 6.70x
Growth
83 /100
Growing Rev. growth 55.76%
Book val. growth 0.17%
EPS growth N/A
Profitability
68 /100
Strong Gross margin 85.28%
Net margin 5.37%
Op. margin 8.37%
Quality
33 /100
Poor ROIC 4.78%
ROE 7.11%
ROA 3.49%
Debt
95 /100
Low Debt/Equity 0.25x
Current ratio 3.41x
Int. coverage 7.68x
Stability
49 /100
Moderate Beta 0.50x
Rev. volatility 16.65%
EPS volatility 59.78%
Ask StockBot about 6160.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John V. Oyler
Employees
12,000
Headquarters
Basel
Upcoming events
05 NOV
Earnings
Upcoming earnings report